QuidelOrtho narrows 2025 revenue guidance to $2.68B–$2.74B as margin initiatives deliver $140M in cost savings

Get key Q3 2025 earnings insights for QuidelOrtho (QDEL): margin gains, core growth, narrowed guidance, and innovation focus.
StockStory.org on MSN

5 Revealing Analyst Questions From QuidelOrtho’s Q3 Earnings Call

QuidelOrtho’s third quarter was marked by a positive market reaction, reflecting solid execution despite a year-on-year ...
WREG

QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay

SAN DIEGO, Nov. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, 510(k ...